Pharmaceuticals News and Research

RSS
Study finds inherited GATA3 gene variation increases risk of developing pediatric leukemia

Study finds inherited GATA3 gene variation increases risk of developing pediatric leukemia

21 Oct 2013
Phase 2b study of JAK3 inhibitor VX-509 shows improvement in people with active RA

Phase 2b study of JAK3 inhibitor VX-509 shows improvement in people with active RA

19 Oct 2013
FDA approves Iroko Pharmaceuticals’ ZORVOLEX capsules

FDA approves Iroko Pharmaceuticals’ ZORVOLEX capsules

19 Oct 2013
Alimera Sciences receives Complete Response Letter for New Drug Application from FDA

Alimera Sciences receives Complete Response Letter for New Drug Application from FDA

19 Oct 2013
Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

Research roundup: Less savings needed for retirement health expenses; falls as a predictor of surgical outcomes

19 Oct 2013
Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

19 Oct 2013
Stem Cell Therapeutics Nabs Sirpa Protein-Targeting Mabs

Stem Cell Therapeutics Nabs Sirpa Protein-Targeting Mabs

18 Oct 2013
Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

18 Oct 2013
ARIAD discontinues Phase 3 EPIC trial of Iclusig in patients with chronic myeloid leukemia

ARIAD discontinues Phase 3 EPIC trial of Iclusig in patients with chronic myeloid leukemia

18 Oct 2013
pSivida reports that Alimera Sciences gets FDA Complete Response Letter for ILUVIEN NDA

pSivida reports that Alimera Sciences gets FDA Complete Response Letter for ILUVIEN NDA

18 Oct 2013
Anacor Pharmaceuticals appoints arbitrator to resolve its dispute with Valeant Pharmaceuticals

Anacor Pharmaceuticals appoints arbitrator to resolve its dispute with Valeant Pharmaceuticals

18 Oct 2013
Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

Altherx Pharmaceuticals receives U.S. patent for use of solabegron for treatment of overactive bladder

18 Oct 2013
Combination of heat, doxorubicin drug and nanotech system may improve ovarian cancer treatment

Combination of heat, doxorubicin drug and nanotech system may improve ovarian cancer treatment

18 Oct 2013
Stem Cell Therapeutics Nabs Sirpa Protein-Targeting Mabs

Stem Cell Therapeutics Nabs Sirpa Protein-Targeting Mabs

17 Oct 2013
Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

Astrazeneca, Taiwan's NRPB Launch Drug Discovery Collaboration

17 Oct 2013
What's in? What's out? Tracking the course of health law changes included in budget talks

What's in? What's out? Tracking the course of health law changes included in budget talks

17 Oct 2013
Light pulses stimulate designer peptides to trigger death pathway in cancerous cells

Light pulses stimulate designer peptides to trigger death pathway in cancerous cells

17 Oct 2013
Imaxio Sells Genomics Division To Hybrigenics

Imaxio Sells Genomics Division To Hybrigenics

16 Oct 2013
Biotech CEO Faces Felony Charge Of Computer Trespass

Biotech CEO Faces Felony Charge Of Computer Trespass

16 Oct 2013
CEO Faces Felony Charge Of Computer Trespass

CEO Faces Felony Charge Of Computer Trespass

16 Oct 2013

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback